Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Study Center, Scottdale

Site Center, Richmond

Study Center, Morgantown

Study Center, Winston-Salem

Study Center, Rocky Mount

Study Center, Salisbury

Study Center, Wilmington

Study Center, Hickory

Site Center, Plantation

Study Center, Birmingham

Site Center, Hendersonville

Study Center, Bristol

Study Center, Knoxville

Site Center, Louisville

Study Center, Brownsburg

Study Center, Evergreen Park

Site Center, Fort Worth

Site Center, The Woodlands

Site Center, Bellevue